Vidisik® (Vidisic®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCarbomerCarbomer
Similar drugsTo uncover
  • Vidisik®
    gel d / eye 
    VALEANT, LLC     Russia
  • Lacropos
    gel d / eye 
    Ursafarm Artsnaymittel GmbH     Germany
  • Ottagel®
    gel d / eye 
    Santen, AO     Finland
    • Dosage form: & nbsp

    eye gel

    Composition:

    1 g of gel contains:

    active ingredients: toarbomer 2.00 mg;

    atExcipients: цetrimide 0.10 mg, sorbitol 40.00 mg, sodium hydroxide 0.84 mg, water for injection 957.06 mg.

    Description:Transparent colorless viscous liquid.
    Pharmacotherapeutic group:Keratoprotective agent
    ATX: & nbsp

    S.01.X.A.20   Artificial tears and other indifferent drugs

    Pharmacodynamics:The main component of Vidisik® is carbomer - a high molecular weight polyacrylic acid compound that creates a viscous hydrophilic film on the surface of the eye that binds water and stabilizes the tear film.
    Pharmacokinetics:

    Because of the large size of the molecule carbomer does not penetrate into the tissues of the eyeball, does not undergo systemic absorption from the lacrimal ducts and does not enter the enterohepatic system, respectively, in feces and urine is not determined.

    Indications:Symptomatic treatment of dry keratoconjunctivitis (dry eye syndrome).
    Contraindications:

    Individual hypersensitivity to any of the components of the drug.

    Carefully:During pregnancy and during breastfeeding (no clinical data are available).
    Pregnancy and lactation:

    Based on the nature of the active substance of the Vidisik® preparation, its composition and properties, it is difficult to assume any restrictions on the use of the drug in pregnant women or breast-feeding women. However, during pregnancy and / or during breastfeeding, the drug should be used only after consultation with a doctor.

    Dosing and Administration:Depending on the severity and severity of symptoms (complaints from the patient) are instilled 3-5 times a day or more, and also 30 minutes before a dream, 1 drop into the lower conjunctival sac.

    To determine the duration of use of Vidisik®, consultation with an ophthalmologist is necessary.

    Side effects:

    Transient "blurring" of vision. In some cases, a reaction of intolerance to the components of the drug is possible. Preservative cetrimide, which is part of the drug, can cause local eye irritation, allergic reactions (burning, redness, sensation of the "foreign body" in the eye) and damage to the corneal epithelium with prolonged or too frequent use.Therefore, long-term treatment should avoid the use of ophthalmic drugs containing preservatives.

    Overdose:Data on drug overdose are absent.
    Interaction:

    Data on interactions with other drugs are not available.

    In cases where additional local therapy is performed, the interval between the administration of Vidisik ® and other ophthalmic preparations should be: eye drops - at least 5 minutes, ophthalmic ointments - at least 15 minutes.

    Due to their physical properties, Vidisik® can prolong the residence time of other ophthalmic drugs in the eye and, thereby, enhance their effect. Therefore Vidisik® should be used last.

    Special instructions:

    Before using Vidisik®, contact lenses should be removed. After the introduction of the drug, they can be re-put on not earlier than 15 minutes.

    If no improvement is noted, signs of eye irritation appear, discontinue use of the drug and seek medical advice.

    Do not touch the tip of the pipette tube to the eye.

    The tube must be closed after each use.

    Effect on the ability to drive transp. cf.and fur:

    After instillation of the drug on the cornea, a thin film forms, which can cause a brief "clouding" of the vision, thereby reducing the reaction rate. Therefore, the management of vehicles and mechanisms should proceed, when the clarity of vision is restored.

    Form release / dosage:

    Eye gel 0.2%.

    Packaging:10 grams per tube of multi-layer laminate 405 "Polyfoil" (PVP layer, aluminum foil, PNP) with a head with a nozzle and a screw cap made of PVP.
    One tube with instructions for use is put in a cardboard box.
    Storage conditions:

    Store at temperatures between 2 and 30 ° C. Keep out of the reach of children.

    Shelf life:

    3 years.

    After opening the tube, store it for no more than 6 weeks.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N015826 / 01
    Date of registration:18.02.2010 / 26.11.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:VALEANT, LLC VALEANT, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspVALEANT LLC VALEANT LLC Russia
    Information update date: & nbsp11.01.2017
    Illustrated instructions
      Instructions
      Up